Acute Defibrillation Study

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed study is designed to characterize defibrillation efficacy in humans for the potential development of a new extravascular implantable cardioverter defibrillator (ICD) system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

NCT02772380

Tachycardia Ventricular Arrhythmias

COMPLETED NA

Extravascular ICD Pilot Study

NCT03608670

Tachycardia Ventricular Arrythmia

COMPLETED NA

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

NCT00510731

Tachycardia, Ventricular Cardiac Sudden Death

WITHDRAWN

Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System

NCT00399217

Ventricular Fibrillation Ventricular Tachycardia

COMPLETED

ExtraVascular Implantable Cardiac Defibrillator Continued Access Study

NCT05049720

Tachycardia Ventricular Arrythmia

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study recruited male and female subjects that met all of the inclusion criteria and none of the exclusion criteria. All subjects were scheduled to undergo surgical procedures outlined in the inclusion criteria. These surgical procedures were chosen as the patient population for this study because these procedures require similar personnel and may require access to similar or the same spaces as the ASD procedure.

The entire ASD study research system was removed prior to proceeding with the subject's planned surgery per standard medical practice, which then proceeded according to the standard of care.

Subjects were followed through their routine post-surgery follow-up visit.

At the time of completing the follow-up visit, the subjects' participation was complete and the subjects exited the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventricular Arrhythmias

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VT/VF induction and defibrillation

Ventricular Tachycardia and Ventricular Fibrillation (VT/VF) induction and defibrillation will be carried out as the invention in all subjects undergoing study procedures.

Group Type EXPERIMENTAL

Defibrillation following induction of VT/VF

Intervention Type DEVICE

Up to 10 VT/VF induction attempts followed by shock(s) delivered by an externally placed ICD and/or external defibrillator.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Defibrillation following induction of VT/VF

Up to 10 VT/VF induction attempts followed by shock(s) delivered by an externally placed ICD and/or external defibrillator.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must be undergoing surgical procedure for approved indications for
* cardiothoracic surgery where a midline sternotomy is planned, or
* implant of a transvenous (TV) ICD or subcutaneous ICD (S-ICD®), or
* VT ablation procedure, or
* VT inducibility testing during Electrophysiology (EP) study
* Subject must be willing to provide Informed Consent
* Subject must be ≥ 18 years old

Exclusion Criteria

* Subject is considered to be at high risk for infection
* Subject has Left Ventricular Ejection Fraction (LVEF) ≤ 20%
* Subject at high risk of stroke
* Subject with an implanted active cardiac or non-cardiac device during study procedure (e.g., ICD, S-ICD®, Pacemaker, Neuro stimulator)
* Subject is pacemaker dependent
* Subject had previous pericarditis or prior sternotomy
* Subject has hiatus hernia or moderate or worse pectus excavatum
* Subject has hypertrophic cardiomyopathy
* Subject has severe aortic stenosis
* Subject has severe proximal three vessel coronary disease (over 70% in each vessel)
* Subject has \>50% left main stem (LMS) disease
* Subject has known skin irritations to the Physio Control Fast Patch ECG Electrode
* Subject is enrolled in a concurrent study that may confound the results of this study, without documented pre-approval from a Medtronic study manager
* Subject has medical conditions that would limit study participation
* Subject is pregnant

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No